A detailed history of Stephens Consulting, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Stephens Consulting, LLC holds 3,508 shares of PFE stock, worth $93,382. This represents 0.03% of its overall portfolio holdings.

Number of Shares
3,508
Previous 3,913 10.35%
Holding current value
$93,382
Previous $109 Million 7.27%
% of portfolio
0.03%
Previous 0.03%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$27.7 - $31.39 $11,218 - $12,712
-405 Reduced 10.35%
3,508 $102 Million
Q2 2024

Jul 29, 2024

BUY
$25.26 - $29.6 $6,542 - $7,666
259 Added 7.09%
3,913 $109 Million
Q1 2024

Apr 17, 2024

SELL
$25.89 - $29.73 $30,834 - $35,408
-1,191 Reduced 24.58%
3,654 $101 Million
Q4 2023

Feb 01, 2024

BUY
$26.13 - $33.94 $26,130 - $33,940
1,000 Added 26.01%
4,845 $139 Million
Q3 2023

Oct 25, 2023

BUY
$32.09 - $37.51 $16,847 - $19,692
525 Added 15.81%
3,845 $128 Million
Q2 2023

Jul 20, 2023

SELL
$36.12 - $41.79 $2,709 - $3,134
-75 Reduced 2.21%
3,320 $122 Million
Q1 2023

Apr 19, 2023

SELL
$39.39 - $51.28 $157 - $205
-4 Reduced 0.12%
3,395 $139 Million
Q3 2022

Jan 19, 2023

BUY
$43.76 - $53.42 $10,852 - $13,248
248 Added 7.87%
3,399 $149 Million
Q2 2022

Jan 19, 2023

SELL
$46.53 - $55.17 $49,787 - $59,031
-1,070 Reduced 25.35%
3,151 $165 Million
Q1 2022

Jan 19, 2023

SELL
$45.75 - $56.69 $40,260 - $49,887
-880 Reduced 17.25%
4,221 $219 Million
Q4 2021

Jan 19, 2023

BUY
$41.32 - $61.25 $210,773 - $312,436
5,101 New
5,101 $301 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $149B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Stephens Consulting, LLC Portfolio

Follow Stephens Consulting, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stephens Consulting, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stephens Consulting, LLC with notifications on news.